The aim of this study is to explore the potential efficacy of IBA as treatment for adolescents with OCD.
ID
Source
Brief title
Condition
- Anxiety disorders and symptoms
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Severity of OCD, measured with the CY-BOCS;
Secondary outcome
OCD symptomatology, measured with three-weekly ratings of the adolescents'
obsessions, compulsions and the level of insight.
Background summary
Adolescents with Obsessive-compulsive Disorder (OCD) have obsessions,
compulsions or both (APA, 2014). OCD is a severe psychiatric disorder,
affecting many aspects of the lives of adolescents (Weidle et al., 2014; Storch
et al., 2018). The first choice treatment for adolescents with OCD is Cognitive
Behavioral Therapy (CBT) (Kenniscentrum KJP; AACAP, 2012), consisting of
exposure with response prevention (ERP) and cognitive interventions (Öst et
al., 2016). Treating adolescents with OCD through CBT leads to significant
symptom reduction in almost 70% of completed treatments (Öst et al., 2016).
However, after completion of treatment, about 50% of adolescents still meet the
criteria for OCD (Öst et al., 2016). Adolescents with OCD who do not
sufficiently benefit from CBT treatment have severe symptoms, including poor or
no insight (Sharma et al., 2021; Nissen & Parner, 2018; Storch et al., 2014).
Considering the substantial group of non-responders to CBT, it is necessary to
have more options for effective treatment of OCD. Inference Based Approach
(IBA) is already an effective treatment for adults with OCD (O*Connor et al.,
2005; Visser et al., 2015) and is more effective on adults with OCD and poor
cognitive insight (Visser et al., 2015). It is hypothesized that IBA could be
an effective alternative for CBT in treating adolescents with OCD. This study
will be a first step in examining the efficacy of IBA as treatment for
adolescents with OCD.
Study objective
The aim of this study is to explore the potential efficacy of IBA as treatment
for adolescents with OCD.
Study design
A non-concurrent multiple baseline design with 8 participants who receive IBA
for 20 sessions perfomed in one psychiatric centre in the Netherlands.
Intervention
20 sessies IBA treatment.
Study burden and risks
No burden or risks are expected due to specific elements of the IBA
intervention used in this study. Contrary to CBT, treatment elements of IBA
will not include exposure to feared consequences while trying to not indulge in
compulsions. On top of that, obsessions will not be questioned or challenged.
These characteristics may help participants stay motivated to complete
treatment and experience improvement in OCD-symptoms.
Delta 1a
Arnhem 6825 ML
NL
Delta 1a
Arnhem 6825 ML
NL
Listed location countries
Age
Inclusion criteria
- Primary DSM-5 diagnosis of OCD.
- A total score of 16 or higher on the CY-BOCS.
- Age between 12 and 17;11.
- Medication must be stable for at least one month.
Exclusion criteria
- No sufficient knowledge of the Dutch language
- Autism spectrum disorder (ASD)
- Mental retardation (TIQ<80)
- Acute suicidality (defined as having suicidal thoughts and plans and/or
preparations to
ending their life)
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL81157.091.22 |